Bioengineering executive Michael Ackermann describes how the unique challenges of the healthcare industry can serve as advantages for entrepreneurs. Once you understand the regulatory landscape and intricacies of the sector’s diverse stakeholders, Ackermann says those same barriers can discourage other entrepreneurs from entering the market. The onetime CEO of a startup that created a tear-stimulation device for those with dry-eye disease, Ackermann explains how capturing even a small slice of the $3 trillion healthcare market is huge.

Video clips from: A Tearful Tale of Biodesign [Entire Talk]

2 minutes

Healthcare Uncertainties Under Trump

Watch now

3 minutes

Entry Barriers as Buffers

Watch now

3 minutes

Acquisition Can Amplify Impact

Watch now

5 minutes

Why Tech Hasn’t Transformed Healthcare

Watch now

5 minutes

Trends and Opportunities in Healthcare

Watch now

Share Post